Key Highlights
● Costco's decision to drop FOCUSfactor after more than 16 years removes a customer that generated roughly 58% of Synergy CHC's 2025 revenue, compounding an already precarious cash position at the small-cap consumer-health company.
● Full-year 2025 revenue fell to $30.38 million from $34.83 million in 2024, and the company has roughly two weeks of cash on hand at the last reporting date, a position that predates the Costco announcement.
● The most immediate risk is liquidity: with roughly two weeks of cash on hand and a customer representing more than half of revenue now gone, Synergy faces acute pressure to secure new distribution or financing.
● Investors should watch Synergy's next quarterly filing for updated cash balances and any new financing or strategic alternatives following the Costco loss.
Synergy CHC Corp., the small-cap owner of the FOCUSfactor brain-health supplement brand, is confronting the most serious crisis in its history. On July 15, 2026, Costco Wholesale notified the company it would stop carrying FOCUSfactor products, ending a distribution relationship of more than 16 years. Synergy disclosed the news in a July 29 SEC filing, warning the loss is expected to have "a material adverse effect" on its business, results of operations, liquidity and financial condition. The disclosure lands just months after Synergy recruited retail and beverage-industry veterans to expand distribution, a sharp reversal of the growth narrative management had been building.
What happened
According to Synergy's July 29 Form 8-K, Costco represented approximately 58% of the company's net revenue in fiscal 2025, making it by far Synergy's largest customer. The retailer's decision to discontinue FOCUSfactor removes the single largest pillar of Synergy's sales base with no stated timeline for reinstatement or replacement. Compounding the concern, Synergy's most recent quarterly filing showed cash of just $292,115 as of March 31, 2026, equivalent to roughly 13 days of operating expenses at the company's first-quarter cash-burn rate, before the Costco news even arrived. Management said it is "evaluating available financing and other strategic alternatives," and pointed to an active shelf registration that permits future securities offerings of up to $100 million, suggesting further dilution is a live possibility.
Why the development matters
Losing a customer responsible for more than half of annual revenue is severe for any company, but especially acute for one already burning cash and carrying substantial debt. Synergy's stock had already fallen roughly 93% over the twelve months to July 1, 2026, to around $0.20 a share, giving it a market capitalization of about $3.1 million even before the Costco disclosure, a sign investors had grown wary well ahead of this latest setback. The Costco relationship was concentrated in FOCUSfactor, Synergy's flagship product, so the impact will likely be felt across the company's core supplement business rather than a smaller side line.
Company and product background
Synergy CHC markets a portfolio of consumer-health and beauty products, most prominently FOCUSfactor, a brain-health and memory supplement, alongside the Flat Tummy weight-management brand. The company sells through mass retail, e-commerce (including Amazon), club channels, and international licensing. Synergy moved from the OTC markets to Nasdaq in October 2024, pricing a public offering at $9 per share for roughly $10 million in gross proceeds, with Roth Capital as sole bookrunner. Since then, management has pursued a stated strategy of diversifying beyond core supplements into functional beverages, including a FOCUSfactor-branded energy drink, and expanding distribution through partners such as EG America, Wakefern Food and Pine State Beverage. In September 2025, Synergy hired Scott Woodburn, a 30-year beverage-industry veteran and former Coca-Cola vice president of national and global accounts, as head of strategic partnerships, and appointed Teresa Thompson, a nearly 30-year Costco pharmacy and OTC buyer, to its board, hires explicitly framed around deepening retail ties, Costco included.
Financial position
Synergy's financial trajectory had already deteriorated well before the Costco announcement. Full-year 2025 revenue fell to $30.38 million from $34.83 million in 2024, and the company swung to a net loss of $12.34 million from net income of $2.12 million a year earlier, driven largely by one-time charges: a $6.66 million bad-debt allowance, a $2.9 million licensing-termination charge tied to a canceled Middle East partnership, and inventory and prepaid-media write-offs. Fourth-quarter 2025 revenue nearly halved year over year to $6.07 million, with gross margin compressing to 36.6% from 63.3%. The slide continued into 2026: first-quarter revenue fell 33% to $5.49 million, and the company posted a net loss of $2.57 million versus net income of $0.88 million a year earlier, partly because a $1.5 million 2025 licensing payment did not recur. As of March 31, 2026, Synergy carried total debt of roughly $27.75 million against cash of just $292,115, and a working-capital deficit of about $0.50 million. It raised roughly $2.7 million through an at-the-market offering after quarter-end and had secured a $20 million long-term credit facility in mid-2025, but thin cash, sizable debt and a collapsing revenue base now leave little room for error.
Bull case
Synergy's functional-beverage push has shown early traction: quarterly beverage revenue exceeded $650,000 in the first quarter of 2026, which management said already surpassed the brand's entire 2025 beverage revenue, implying an annualized run rate above $4 million. If that segment continues scaling and diversifies Synergy's customer base away from any single retailer, it could partially offset the Costco loss over time. The company's access to an active shelf registration and demonstrated ability to raise capital via credit facilities and at-the-market offerings gives it at least a mechanism, however dilutive, to fund operations while it seeks new retail partners or a resolution with Costco.
Risk case
The most immediate risk is liquidity: with roughly two weeks of cash on hand at the last reporting date and a customer representing more than half of revenue now gone, Synergy faces pressure to secure financing quickly, likely on unfavorable terms given its depressed share price and existing debt load. Further shareholder dilution is probable given the company's stated intent to explore financing alternatives under its $100 million shelf. There is no guarantee FOCUSfactor regains Costco shelf space, and replacing that volume elsewhere would likely take considerable time. A history of one-time charges, a terminated Middle East license, and swinging profitability also raises questions about the durability of any recovery plan.
What investors should watch next
Investors should watch for: any updates on financing or strategic alternatives management pursues in response to the Costco loss; Synergy's next quarterly filing (Q2 2026) for updated cash balances, revenue trends and going-concern language; further disclosures on whether Costco's decision is permanent or subject to renegotiation; continued growth trajectory of the functional-beverage segment as a potential offset; and any additional capital raises under the company's shelf registration, which would clarify the scale of dilution shareholders may face.
Conclusion
Synergy CHC now faces a defining test just as it had begun positioning itself for growth via beverage diversification and new retail relationships. The loss of a customer generating more than half of last year's revenue, layered atop an already thin cash position and substantial debt, creates real uncertainty about the company's near-term financial footing. Whether Synergy can secure financing, rebuild its retail footprint, and scale newer product lines quickly enough to offset the Costco gap will likely determine its trajectory over coming quarters. Investors should weigh the company's own characterization of the Costco loss as a material adverse event, while recognizing the financial and strategic response remains unfolding.
This article is for informational purposes only and does not constitute investment advice or a recommendation to buy, sell, or hold any security. Share prices can rise or fall, and past performance does not guarantee future results. Investors should conduct independent research and consult a licensed financial adviser before making investment decisions.






Please wait processing your request...